Genexine, Inc.

Quick facts

Phase 3 pipeline

• NESP · Nephrology
  NESP is a recombinant human erythropoietin analog that stimulates erythropoiesis.

Phase 2 pipeline

• GX-188E
• GX-E2
• Gx-G6
• GX-H9
• GX-I7 · Diabetes
  GX-I7 is a recombinant human fibroblast growth factor 21 (FGF21) protein.

Phase 1 pipeline

• GX-051
• HBsAg vaccine with Entecavir
• Period 1 GX-30, Period 2 THYROGEN®
• Period 1 THYROGEN®, Period 2 GX-30

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Genexine, Inc. portfolio CI brief
• Genexine, Inc. pipeline updates RSS